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Smoking and pregestational diabetes (PGD) are recognized risk factors for adverse pregnancy outcomes, but to date, no population-
based study has investigated their joint effects. Using hospital discharges, we identified all women with PGD delivering in Emilia-
Romagna region during 2007–2010 matched 1 : 5 with parturients without diabetes. Our study endpoints were preterm births and
congenital anomalies. We measured interaction between PGD and maternal smoking, by calculating excess prevalence and
prevalence ratio due to interaction, relative excess risk due to interaction (RERI), attributable proportion (AP), and the synergy
index (S). Analyses were performed in the overall study population and in the subgroup whose PGD was validated through
diabetes registers. The study included 992 women with PGD (10.5% smokers) and 4788 comparison women (11.9% smokers).
The effects of PGD and maternal tobacco smoking were greater than additive for both preterm birth (excess prevalence due to
interaction = 11.7%, excess ratio due to interaction = 1.5, RERI = 2.39, AP = 0.51, S = 2.82) and congenital anomalies (excess
prevalence due to interaction = 2.2%, excess ratio due to interaction = 1.3, RERI = 1.33, AP = 0.49, S = 5.03). Joint effect on both
endpoints was confirmed in the subgroup whose PGD status was validated. In conclusion, we found that maternal tobacco
smoking and PGD intensify each other’s effect on preterm birth and congenital anomalies.
1. Introduction
Tobacco smoking during pregnancy is one of the main
modifiable risk factors associated with adverse maternal
and fetal outcomes, including intrauterine growth restric-
tion, ectopic pregnancy, premature birth, and congenital
anomalies [1–4]. Pregnancy therefore represents a unique
motivation for smoking cessation, and more women quit
smoking during pregnancy than at any other time in their
lives [5]. However, despite the known risks, the majority
of women smoking at conception continue to smoke. More
than 10% of women smoke during pregnancy in many high-
income countries [6, 7]. In Italy, epidemiologic studies and
routinely collected health data show that tobacco smoking
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prevalence among pregnant population varies from 6.7% to
22.3%. Tobacco smoking is associated with young maternal
age and low economic status or education level [8–11].
Pregestational diabetes (PGD) represents the most com-
mon chronic condition complicating pregnancy. The num-
ber of affected pregnancies has been increasing, largely due
to the obesity epidemic and consequent increase in type 2
diabetes in younger women [12, 13]. Several studies showed
that PGD is an important risk factor for adverse pregnancy
outcomes. In particular, women with existing diabetes have
a risk of pregnancy resulting in major structural congenital
anomaly up to fourfold greater than women without PGD
[14–18]. In addition, the risk of preterm delivery, either
spontaneous or indicated, was increased in women with
pregnancies complicated by PGD, with studies reporting
rates up to sevenfold higher than that among women not
affected [19–21].
While maternal smoking and diabetes have been both
recognized as independent relevant risk factors for adverse
pregnancy outcomes, little is known about their interaction.
Nicotine, one of the major bioactive substances in cigarettes,
has been shown to alter glucose homeostasis, implying an
important role for this agent in the development of cardio-
metabolic and other complications in diabetic patients [22].
Moreover, tobacco smoking seems able to amplify the effect
of some risk factors on outcomes such as cardiovascular mor-
tality or diseases, disability, and gestational diabetes, imply-
ing synergism between smoking and other factors [23–27].
The aim of this study was to investigate the joint effect
of smoking and PGD on the risk of preterm birth and
congenital anomalies in a population-based cohort of Italian
pregnant women.
2. Materials and Methods
2.1. Study Population. Following approval by the Modena
Province Ethics Committee, we conducted a retrospective
cohort study by identifying all deliveries in Emilia-Romagna
region (Northern Italy, population about 4,000,000) in the
2007–2010 period through the Hospital Discharge (HD)
database (International Classification of Diseases version 9
Clinical Medicine (ICD-9-CM) codes V27.0-V27.9). We
selected parturients with PGD through the presence of ICD-
9-CM codes 250.xx or 648.0x listed anywhere on the HD
records. For each selected HD record, we matched five com-
parison mothers without diabetes, according to year of birth
and delivery, province of residence, and referral hospital.
Among all mothers who matched the index mother by these
criteria, we randomly selected the five comparators. To carry
out this sampling of matched comparison women, we used
the STATA-12 optmatch2 routine. If five womenwithout dia-
betes were not available to match a woman with diabetes, we
accepted a lower number. No matched woman was available
for 2.3% of the women with diabetes. For these women, we
relaxed the matching criteria first for province of residence,
then for hospital of delivery, and finally for year of delivery.
Women who experienced more than one delivery during the
4-year study period were included as multiple observations.
Twin pregnancies were excluded.
We used the birth certificates to collect information on
tobacco smoking habits of the mother, as well as on other
sociodemographic and clinical characteristics used as covari-
ates in the analysis (nationality, maternal age at the time of
delivery, and education level of both parents). Smoking
habits during pregnancy were therefore self-reported by
mothers. Maternal smoking was defined as smoking for any
period during pregnancy. Thus, it includes both women
smoking only in early pregnancy and women smoking
throughout pregnancy, regardless of the number of cigarettes
smoked. Women who never smoked or who quit smoking
before pregnancy were considered nonsmokers. Missing data
on smoking habit during pregnancy was considered as an
exclusion criterion in the selection of the study population.
Method for selecting the study population is shown in
Figure 1.
Lastly, through the population-based diabetes registers
recently established in two out of nine provinces of the
Emilia-Romagna region [28], Modena and Reggio-Emilia,
we validated PGD diagnosis for the subgroup of women
residing in these two provinces. Diabetes registers are based
on case identification algorithms involving both administra-
tive and clinical data, so their data tend to be more complete
and accurate than data from other sources [29].
2.2. Pregnancy Adverse Outcomes. We focused on two
adverse pregnancy outcomes, preterm births and congenital
anomalies. We defined preterm birth as gestational age at
delivery, according to the birth certificate, of <37 weeks.
We detected congenital anomalies by matching each selected
birth certificate to the Registry of Birth Defects of the Emilia-
Romagna Region named IMER (Indagine sulle Malforma-
zioni congenite in Emilia Romagna). This registry, established
in 1978, is part of the European Network for the Surveillance
of Congenital Anomalies EUROCAT [30].
2.3. Data Analysis. We measured the interaction between
tobacco smoking and PGD as the excess over additivity of
effects, comparing the combined effect of the two exposures
with the sum of their individual effects. Firstly, we computed
prevalence difference (PD) and prevalence ratio (PR) with
associated 95% confidence interval (CI) of preterm birth
and congenital anomalies using Episheet statistical software
(version of April 10, 2017, downloaded from http://
krothman.org/Episheet.xls). Women without PGD and non-
smokers represented the reference category. Excess preva-
lence of preterm birth and congenital anomalies due to
interaction was calculated as the difference between PD in
women exposed to both smoking and PGD (PD11) and the
sum of PD in women exposed to only smoking (PD01) or only
PGD (PD10) (excess prevalence due to interaction=PD11−
(PD01 +PD10)). Excess ratio due to interaction was calculated
as PR11−PR01−PR10 + 1 [31].
Then, we measured departures from additivity using
appropriately defined relative measures of effect derived from
multiplicative regression models. We estimated relative risks
(RRs) from the odds ratios generated by logistic regression
models, introducing PGD and maternal smoking in the
models as a product term. In this model, we included
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maternal age at delivery, nationality, and parents’ education
as confounding variables. We used the estimates from logistic
regression models to calculate the relative excess risk due to
interaction (RERI), the attributable proportion due to inter-
action (AP), and the synergy index (S), using an Excel
spreadsheet by Andersson et al. [32]. RERI should be inter-
preted as the relative excess risk (RR-1) in those with both
exposures minus that expected on the basis of the sum of
the relative excess risks for the individual exposures. The
AP represents the proportion of disease that is due to interac-
tion among persons with both exposures. The synergy index
S measures the extent to which the joint effect for both factors
together, expressed as the relative excess risk, which exceeds
the sum of the relative excess risk for each of the two factors’
separate effect [33, 34].
Statistical analyses were performed by using Stata 15
statistical software (StataCorp LP, College Station, TX).
3. Results
The study included 5780 pregnant women, among them 992
with PGD and 4788 without PGD (Figure 1). The prevalence
of tobacco smoking was similar among women with and
without PGD (10.5% and 11.9%, resp.). General characteris-
tics of the study population are presented in Table 1. Overall,
we identified 536 (9.3%) preterm births and 118 (2.1%)
newborns with one or more congenital anomalies.
Prevalence differences, PRs and RRs of preterm birth and
congenital anomalies are reported in Table 2. We used these
results to calculate measures of interaction between PGD and
tobacco smoking, and we found that the effects were greater
than additive for both preterm birth and congenital anoma-
lies. The excess prevalence of preterm birth due to interaction
was 11.7%, and the excess ratio of preterm birth due to inter-
action was 1.5. The joint effects on preterm birth were con-
firmed also when confounding variables were considered,
with RERI= 2.39 (95% CI: 0.25, 4.53), AP=0.51 (95% CI:
0.26, 0.75), and S=2.82 (95% CI: 1.39, 5.79). An AP of 0.51
for preterm birth means that we estimate that 51% of the pre-
term births occurring to women who had diabetes and were
smokers is attributable to the interaction between these two
risk factors, assuming all the effects are causal and biases
are controlled. As for congenital anomalies, we found excess
prevalence due to interaction =2.2%, excess ratio due to inter-
action=1.3, RERI= 1.33 (95% CI: −1.19, 3.88), AP=0.49
(95% CI: 0, 1.05), and S= 5.03 (95% CI: 0.23, 42.25). The AP
Hospital discharges with ICD-9-CM codes V27.0-V27.9 in Emilia-Romagna in the study period
(total deliveries)
N = 153,918
Hospital discharges with ICD-9-CM codes
250.xx or 648.0x
(parturients with pregestational diabetes, PGD)
N = 1139
Parturients with PGD
excluding twin pregnancies
N = 1,125
Exclusion criteria:
twin pregnancies (N = 14)
Parturients without PGD
matched according to year of birth and delivery,
province of residence and referral hospital
N = 5268⁎
Parturients without PGD
N = 4788⁎⁎
Exclusion criteria:
missing data on smoking
habits during pregnancy
(N = 480)
Parturients with PGD
N = 992
Exclusion criteria:
missing data on
smoking habits during
pregnancy (N = 133)
Total study population
N = 5780
Figure 1: Flowchart of the study population. ∗ 954 cases matched 5 controls, 66 cases matched 4 controls, 49 cases matched 3 controls, 31
cases matched 2 controls and 25 cases matched 1 control. ∗∗ 921 cases matched 5 controls, 22 cases matched 4 controls, 17 cases matched
3 controls, 12 cases matched 2 controls and 20 cases matched 1 control.
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of 0.49 indicates again that about half of the occurrence of
births with congenital anomalies can be attributed to the
interaction of tobacco smoking with pregestational diabetes.
Effect estimates for major categories of congenital anom-
alies were statistically unstable because of the small number
of subjects. The congenital anomalies for which prevalence
was considerably increased among diabetic women who also
smoked during pregnancy were those affecting the cardiovas-
cular system (RR=2.88, 95% CI: 0.67–12.37), the genitouri-
nary system (RR=3.46, 95% CI: 0.43–27.62), and cleft
palate/lip (RR=7.42, 95% CI: 0.85–64.71), with RERI =2.70
(95% CI: −1.52–6.91), 0.58 (95% CI: −6.88–8.05), and 4.96
(95% CI: −10.73–20.64), respectively. Concerning only
anomalies of the cardiovascular system, which accounted
for the highest number of congenital anomalies, we assessed
the single anomalies, and we found that the increased risk in
the offspring of women both smoking and affected by diabe-
tes involved mainly atrial septal defects (RR=9.29, 95% CI:
1.04–83.13), with RERI =8.02 (95% CI: −12.05–28.09).
The analysis restricted to the subgroup of women vali-
dated through provincial diabetes registers of Modena and
Reggio-Emilia included 108 women with PGD and 513 com-
parison women. Prevalence differences, PRs and RRs of pre-
term birth, and congenital anomalies among these women
are reported in Table 3. Patterns were similar among these
validated cases, but subject tomore variation as a consequence
of the small number of validated cases (for preterm birth,
excess prevalence due to interaction=5.3%, excess ratio due
to interaction =0.6, RERI = 1.75 (95% CI: −7.14, 10.63),
AP=0.29 (95% CI: 0, 1.37), S = 1.54 (95% CI: 0.24, 9.75) and
Table 1: Demographic characteristics of the study population, according to maternal pregestational diabetes and smoking habits.
Women with PGD Women without PGD
Nonsmoking Smoking Total Nonsmoking Smoking Total
n (%) n (%) n n (%) n (%) n
Age at delivery
<35 years 502 (56.5) 68 (65.4) 570 2469 (58.5) 337 (59.1) 2806
≥35 years 386 (43.5) 36 (34.6) 422 1749 (41.5) 233 (40.9) 1982
Nationality
Italian 465 (52.4) 89 (85.6) 554 3157 (74.8) 511 (89.6) 3668
Other 423 (47.6) 15 (14.4) 438 1061 (25.2) 59 (10.4) 1120
Education
Elementary/middle school 383 (43.1) 42 (40.4) 425 1129 (26.8) 181 (31.8) 1310
High school 360 (40.5) 42 (40.4) 402 1883 (44.6) 288 (50.5) 2171
University 145 (16.3) 20 (19.2) 165 1206 (28.6) 101 (17.7) 1307
Father’s education
Elementary/middle school 423 (47.6) 49 (47.1) 472 1362 (32.3) 236 (41.4) 1598
High school 314 (35.4) 44 (42.3) 358 1734 (41.1) 240 (42.1) 1974
University 110 (12.4) 10 (9.6) 120 903 (21.4) 72 (12.6) 975
Missing 41 (4.6) 1 (1.0) 42 219 (5.2) 22 (3.9) 241
Total 888 (100.0) 104 (100.0) 992 4218 (100.0) 570 (100.0) 4788
PGD= pregestational diabetes.
Table 2: Prevalence difference per 100, prevalence ratio and relative risk of preterm birth, and congenital anomalies associated with
pregestational diabetes and/or tobacco smoking, Emilia-Romagna region, 2007–2010.
PGD Smoking Total n (%) PD∗100 (95% CI) PR (95% CI) RR∗ (95% CI)
Preterm birth
No No 4218 317 (7.51) Ref. Ref. Ref.
No Yes 570 39 (6.84) −0.67 (−2.89, 1.54) 0.91 (0.66, 1.25) 0.89 (0.63, 1.27)
Yes No 888 151 (17.01) 9.48 (6.89, 12.08) 2.26 (1.89, 2.70) 2.41 (1.93, 3.02)
Yes Yes 104 29 (27.88) 20.36 (11.67, 29.06) 3.71 (2.67, 5.15) 4.69 (2.97, 7.41)
Congenital anomalies
No No 4218 79 (1.87) Ref. Ref. Ref.
No Yes 570 10 (1.75) −0.12 (−1.27, 1.03) 0.93 (0.49, 1.79) 0.92 (0.47, 1.79)
Yes No 888 24 (2.70) 0.83 (−0.31, 1.97) 1.44 (0.92, 2.26) 1.41 (0.88, 2.25)
Yes Yes 104 5 (4.81) 2.93 (−1.22, 7.08) 2.57 (1.06, 6.23) 2.66 (1.05, 6.71)
∗Adjusted for maternal age at delivery, nationality, and parents’ education level. PGD= pregestational diabetes; PD = prevalence difference; PR = prevalence
ratio; RR = relative risk.
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for congenital anomalies, excess prevalence due to interac-
tion=3%, excess ratio due to interaction= 2.2, RERI =5.44
(95% CI: −23.03, 33.91), AP=0.42 (95% CI: 0, 1.75), S = 1.84
(95% CI: 0.14, 21.19)).
4. Discussion
This is the first population-based study evaluating the inter-
action between diabetes and tobacco smoking in the specific
population of pregnant women. Among women with both
PGD and smoking, we found 11 preterm births and 2 con-
genital anomalies per 100 newborns more than we would
expect on the basis of the sum of the separate effects of
PGD and smoking, consistent with the presence of causal
interaction between the two factors. In particular, calculation
of AP showed that 51% of preterm births and 49% of congen-
ital anomalies that occurred in the offspring of women with
PGD and tobacco smoking habit were attributable to the
interaction of the two exposures. This excess risk over addi-
tivity of effects was confirmed in the analysis performed on
the subpopulation validated through the provincial diabetes
registers. Despite the limited statistical stability from small
numbers in this subgroup, the analysis of the provincial Dia-
betes Registers is reassuring, considering the higher accuracy
in identifying cases of diabetes mellitus in this data source.
Indeed, two Canadian and American studies [35, 36] have
already highlighted that the use of only administrative data
to identify diabetes in populations such as pregnant women
could involve substantial misclassifications, mainly due to a
limited ability to distinguish between pregestational and
gestational diabetes.
These results are consistent with the hypothesis that PGD
has effects that make offspring of affected women more sus-
ceptible to the effects of tobacco smoke. The negative effect
of tobacco smoking on glycemic control, which has been
already demonstrated [37], could partially explain the joint
effect between the two risk factors. In fact, poor glycemic
control at preconception or during pregnancy has been
identified as one of the main factors associated with adverse
pregnancy outcomes in women with diabetes [37–39].
Among the limitations of our study are considerable sta-
tistical variability of some estimates and lack of information
about the metabolic status of the diabetic women. In addi-
tion, there are the possible confounding effects of concomi-
tant obesity, folic acid consumption, and drug prescription
at the time of pregnancy. We could not retrieve information
about these variables for both parturients with and without
diabetes. In addition, some exposure misclassification may
have occurred for tobacco smoking during pregnancy,
because of possible underreporting in studies relying on
self-report [40]. Lack of availability of individual data, how-
ever, is frequently an inherent limitation of studies based
on administrative or registry databases like the present one.
On the other hand, administrative data affords much larger
study sizes and may reduce selection bias. Lastly, given the
high prevalence of preterm births in the doubly exposed
group, the adjusted odds ratios derived from the logistic
regression are slight overestimates of the prevalence ratios.
These results have greater importance because the
prevalence of tobacco smoking during pregnancy remains
high, as we found here, and was also reported in previous
studies [8–11]. This is the first study reporting the prevalence
of tobacco smoking among Italian pregnant women with
PGD, and we unexpectedly found that it was similar to that
found among pregnant women without PGD (more than
10%). This finding is concerning in view of the adverse risks
related to diabetes and more so as a result of the interaction
between the two factors.
5. Conclusions
In conclusion, our results indicate an interaction between
maternal tobacco smoking and pregestational diabetes in
increasing the risk of preterm birth and congenital anomalies.
Given the still high prevalence of smokers among pregnant
women, including thosewithPGD,and the interactive relation
with PGD, further efforts to discourage smoking during
pregnancy among women with diabetes would have a con-
siderable public-health benefit. Further studies, including
larger samples of pregnant women, would help to clarify
Table 3: Prevalence difference per 100, prevalence ratio and relative risk of preterm birth, and congenital anomalies associated with
pregestational diabetes and/or tobacco smoking, Provinces of Modena and Reggio Emilia, 2007–2010.
PGD Smoking Total n (%) PD∗100 (95% CI) PR (95% CI) RR (95% CI)
Preterm birth
No No 449 40 (8.91) Ref. Ref. Ref.
No Yes 64 7 (10.94) 2.02 (−6.12, 10.17) 1.23 (0.57, 2.64) 1.30 (0.55, 3.08)
Yes No 100 30 (30.01) 21.09 (11.68, 30.49) 3.37 (2.21, 5.14) 3.94 (2.25, 6.92)
Yes Yes 8 3 (37.50) 28.6 (−7.37, 64.55) 4.21 (1.55, 11.51) 5.99 (1.37, 26.29)
Congenital anomalies
No No 449 6 (1.34) Ref. Ref. Ref.
No Yes 64 3 (4.69) 3.35 (−1.97, 8.67) 3.51 (0.89, 13.81) 4.46 (1.04, 19.09)
Yes No 100 6 (6.01) 4.66 (−0.13, 9.46) 4.49 (1.47, 13.71) 4.01 (1.22, 13.18)
Yes Yes 8 1 (12.50) 11.16 (−13.36, 35.68) 9.35 (1.13, 77.62) 12.91 (1.30, 127.75)
∗Adjusted for maternal age at delivery, nationality, and parents’ education level. PGD= pregestational diabetes; PD = prevalence difference; PR = prevalence
ratio; RR = relative risk.
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the extent of this benefit as well as to deeply understand
the relation between smoking and diabetes on adverse
pregnancy outcomes.
Abbreviations
PGD: Pregestational diabetes
HD: Hospital discharge
ICD: International Classification of Diseases
IMER: Indagine sulle Malformazioni congenite in Emilia
Romagna (Registry of Birth Defects of the Emilia-
Romagna Region)
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PR: Prevalence ratio
RR: Relative risk
RERI: Relative excess risk due to interaction
AP: Attributable proportion due to interaction
S: Synergy index.
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